Respiratory health · Asthma
BATURA
Phase IIIb decentralized study of as-needed PT027 versus PT007.
- Population
- Asthma, ages 12 and older
- Protocol
- AV007
- Organizations listed in records
- Bond Avillion 2 Development LP / Parexel
Clinical research programs
Explore Spectrum’s clinical research programs across respiratory health, endocrinology, wound care, and diagnostic testing.
Draft for review — study roles and completion status are being confirmed. The 10 documented study program records are not 10 completed trials. Spectrum’s CRO role on Haelan 951 is confirmed; enrollment and completion are not established.
Registry-linked programs
The registry links identify the public studies. Spectrum’s specific role, local activity and completion status remain under review.
Respiratory health · Asthma
Phase IIIb decentralized study of as-needed PT027 versus PT007.
Respiratory health · Asthma
Phase IIIb, 52-week study of PT027 versus PT007.
Respiratory health · COPD
Phase III comparison of BGF triple inhaler versus GFF double inhaler.
Respiratory health · COPD
Tanimilast added to maintenance triple therapy.
Wound care · Diabetic foot ulcers
XWRAP allograft plus standard care versus standard care.
Additional documented programs
Supporting records have been identified for these programs. Registry matching and Spectrum’s study-specific role or status still need confirmation.
Endocrinology · Hypothyroidism
Phase 2 desiccated thyroid versus levothyroxine. Agreement found.
Registry match under review
Endocrinology · Type 1 diabetes
Safety and tolerability in newly diagnosed patients. Final executed agreement found.
Registry match under review
Diagnostic testing · Influenza
Influenza home-test diagnostic performance. Signed agreement found.
Registry match under review
Wound care · Venous leg ulcers
InnovaMatrix AC for venous leg ulcers. Protocol to be confirmed from the addendum.
Registry match under review
Participant coordination · Narcolepsy
Participant identification, recruitment, referral and medical-record coordination for a high-sodium oxybate to XYWAV blood-pressure switch study. Specific role confirmation pending.
Registry match under review
Spectrum’s CRO role
For this project, Spectrum serves as the Contract Research Organization (CRO), coordinating study operations for the sponsor. This record is separate from the 10 programs above and does not establish completed enrollment or study outcomes.
Completion and enrollment have not been confirmed.
Work with Spectrum